Non-drug evidence map · Neuromodulation and electrical stimulation

Other neuromodulation

145 registered trials across 36 conditions, from ClinicalTrials.gov.

Other approaches that aim to change nervous-system activity with a device. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

145registered trials
36conditions
57completed
15with results posted
37recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Overactive Bladder
Show trials
188 27 10300
Attention Deficit-Hyperactivity Disorder
Show trials
178 20 12179
Epilepsy
Show trials
133 23 6225
Migraine Disorder
Show trials
115 23 9140
Parkinson Disease
Show trials
103 06 593
Tinnitus
Show trials
96 11 7275
Schizophrenia
Show trials
84 01 784
Major Depressive Disorder
Show trials
61 23 6200
Opioid Use Disorder
Show trials
62 11 435
Low Back Pain
Show trials
52 01 3150
Alcohol Abuse
Show trials
31 02 2102
Fibromyalgia
Show trials
32 00 340
Heart Failure
Show trials
30 02 2158
Long COVID
Show trials
31 00 344
Multiple Sclerosis
Show trials
31 00 145
Obstructive Sleep Apnea
Show trials
31 01 048
Anxiety
Show trials
21 01 2240
Cervical Cancer
Show trials
20 00 128
Gastroparesis
Show trials
21 00 1150
Inflammatory Bowel Disease
Show trials
21 01 1137
Insomnia
Show trials
21 10 287
Irritable Bowel Syndrome
Show trials
21 20 08
Ischemic Stroke
Show trials
20 02 240
Asthma
Show trials
11 00 1106
Bipolar Disorder
Show trials
10 01 164
Breast Cancer
Show trials
10 01 1104
Cystic Fibrosis
Show trials
10 10 01
Diabetic Neuropathy
Show trials
11 00 175
Endometriosis
Show trials
10 00 050
Essential Hypertension
Show trials
10 00 020
Huntington Disease
Show trials
11 00 148
Interstitial Cystitis
Show trials
11 00 188
Obesity
Show trials
10 00 06
Osteoarthritis
Show trials
10 00 150
Restless Legs Syndrome
Show trials
10 00 020
Rheumatoid Arthritis
Show trials
10 01 016

What these trials measure

Primary outcomes, grouped by keyword rules: Symptom severity and disease activity (54), Feasibility, adherence and safety (22), Pain (22), Mood, anxiety and wellbeing (17), Inflammation and other biomarkers (14), Cognition (11), Physical function and exercise capacity (10), Quality of life (8), Sleep (7), Clinical events, survival and healthcare use (3), Heart rate, blood pressure and autonomic (3), Fatigue and energy (2), Breathing and lung function (1).

Names used for this class in the registry

neurofeedback, neurostimulation, sacral neuromodulation, neuromodulation, real-time fmri neurofeedback, non-invasive neuromodulation, fnirs-based neurofeedback, neurofeedback treatment, mobile neurofeedback, neurofeedback training, nirs neurofeedback, percutaneous neurostimulation

Download all 145 trials (CSV) All non-drug classes

Related in Neuromodulation and electrical stimulation: Transcranial brain stimulation (tDCS, TMS) · Vagus and cranial nerve stimulation · Peripheral electrical and electromagnetic stimulation

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.